196 related articles for article (PubMed ID: 16779539)
1. Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas.
Guarise A; Venturini S; Faccioli N; Pinali L; Morana G
Radiol Med; 2006 Jun; 111(4):526-38. PubMed ID: 16779539
[TBL] [Abstract][Full Text] [Related]
2. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.
Worawattanakul S; Semelka RC; Noone TC; Calvo BF; Kelekis NL; Woosley JT
Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
[TBL] [Abstract][Full Text] [Related]
5. [MR cholangiopancreatography and MR imaging in the diagnosis of extrahepatic cholangiocarcinoma].
Zhou JX; Liang BL; Xu LY; Huang SQ
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):421-3. PubMed ID: 15355648
[TBL] [Abstract][Full Text] [Related]
6. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Guthrie JA; Ward J; Robinson PJ
Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of cholangiocarcinoma.
Manfredi R; Barbaro B; Masselli G; Vecchioli A; Marano P
Semin Liver Dis; 2004 May; 24(2):155-64. PubMed ID: 15192788
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis: MR imaging features.
Ito K; Mitchell DG; Outwater EK; Blasbalg R
AJR Am J Roentgenol; 1999 Jun; 172(6):1527-33. PubMed ID: 10350284
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral intrahepatic cholangiocarcinoma. The role of imaging diagnosis and fine-needle biopsy].
Matricardi L; Lovati R; Provezza A; Capra S; Grazioli L; Casoni S; Callea F
Radiol Med; 1996 Apr; 91(4):413-9. PubMed ID: 8643851
[TBL] [Abstract][Full Text] [Related]
14. Biliary dilatation: differentiation of benign from malignant causes--value of adding conventional MR imaging to MR cholangiopancreatography.
Kim MJ; Mitchell DG; Ito K; Outwater EK
Radiology; 2000 Jan; 214(1):173-81. PubMed ID: 10644119
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP.
Yu XR; Huang WY; Zhang BY; Li HQ; Geng DY
Clin Radiol; 2014 Jun; 69(6):567-73. PubMed ID: 24581958
[TBL] [Abstract][Full Text] [Related]
16. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
Matsuo M; Kanematsu M; Itoh K; Ito K; Maetani Y; Kondo H; Kako N; Matsunaga N; Hoshi H; Shiraishi J
AJR Am J Roentgenol; 2001 Sep; 177(3):637-43. PubMed ID: 11517061
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition].
Mougenel JL; Hudziak H; Ernst O; Dupas B; Lefevre F; Barraud H; Watelet J; Cezard O; Regent D; Bigard MA
Gastroenterol Clin Biol; 2000 Oct; 24(10):888-95. PubMed ID: 11084424
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging.
Grubnic S; Padhani AR; Revell PB; Husband JE
AJR Am J Roentgenol; 1999 Jul; 173(1):173-8. PubMed ID: 10397122
[TBL] [Abstract][Full Text] [Related]
19. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
20. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
